According to a newly published market research report by 24LifeSciences, global drugs for schistosomiasis market was valued at USD 80.6 million in 2024 and is projected to reach USD 106.0 million by 2032, growing at a compound annual growth rate (CAGR) of 4.1% during the forecast period 2025–2032. Schistosomiasis, commonly referred to as bilharzia or snail fever, is a neglected...